Strategic Fit PhyNexus, now part of Biotage, provides automated, high-throughput PhyTip chromatography solutions compatible with major robotic systems, presenting an opportunity to upsell Biotage's broader chromatography and automation portfolio to researchers seeking scalable purification workflows.

Automation Ecosystem The platform supports 96-sample parallel processing and compatibility with multiple robotics ecosystems, indicating a strong entry point for selling integrated automation packages, software scripts, and turnkey bench-top systems to labs aiming to increase throughput.

Targeted Applications Capacities cover plasmid and protein purification, CoIP/IP/ChIP, affinity and ion exchange chemistries, and glycosylation analysis, suggesting cross-sell opportunities into Biotage’s bioprocessing and analytical product lines for drug discovery, screening, and process development teams.

Global Expansion Signals Biotage’s recent acquisitions and international expansion (Singapore office, portfolio broadening with Astrea and DPX Technologies) imply growing demand for chromatography solutions worldwide, presenting sales opportunities in new geographies and within integrated product suites.

Revenue and Growth With a revenue range of one to ten million and a focused niche in high-purity, high-concentration separations, there is potential to target mid-market biopharma and contract research organizations seeking scalable, automated purification capabilities from a trusted, broader supplier.